Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026
Go back to Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026| (NASDAQ: KRYS) | Delayed: 358.24 -13.23 (3.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $371.47 | 52 Week High | $ | |||
| Open | $365.45 | 52 Week Low | $ | |||
| Day High | $371.99 | P/E | N/A | |||
| Day Low | $353.75 | EPS | $ | |||
| Volume | 323,017 | |||||

